Table 1. Clinical features of recruited patients.
| Patient ID | Age (years) /Sex | Onset Age (years) |
BCVA (logMAR) |
Optic disc | VEP | |
|---|---|---|---|---|---|---|
| OD | OS | |||||
| OA01-II:3 |
60/F |
3 |
0.02 |
0.01 |
Pale |
NA |
| OA01-III:1 |
38/M |
8 |
0.1 |
0.1 |
Pale |
NA |
| OA01-IV:1 |
16/F |
5 |
0.05 |
0.05 |
Pale |
NA |
| OA02-II:2 |
30/F |
Infant |
0.25 |
0.02 |
Pale |
Diminished |
| OA03-II:1 |
8/M |
3 |
0.2 |
0.3 |
Pale |
NA |
| OA04-II:2 |
10/M |
6 |
0.5 |
0.5 |
Pale |
NA |
| OA05-II:1 |
10/M |
6 |
0.4 |
0.5 |
Pale |
NA |
| OA06-I:1 |
42/M |
12 |
0.5 |
0.4 |
Pale |
NA |
| OA06-II:1 |
14/F |
11 |
0.2 |
0.1 |
Pale |
NA |
| OA07-II:2 |
9/M |
4 |
0.4 |
0.3 |
Pale |
NA |
| OA08-I:1 |
32/M |
8 |
0.3 |
0.3 |
Pale |
Diminished |
| OA08-II:1 |
9/M |
5 |
0.5 |
0.4 |
Pale |
Diminished |
| OA09-II:1 |
8/M |
5 |
0.1 |
0.1 |
Pale |
NA |
| OA10-II:2 |
9/M |
7 |
0.2 |
0.2 |
Pale |
NA |
| OA11-II:1 |
43/F |
12 |
0.1 |
0.1 |
Pale |
NA |
| OA11-II:2 |
42/F |
10 |
0.1 |
0.1 |
Pale |
NA |
| OA12-I:1 |
30/M |
8 |
0.3 |
0.3 |
Pale |
Diminished |
| OA12-II:1 |
6/M |
4 |
0.3 |
0.3 |
Pale |
Diminished |
| OA13-I:2 |
31/F |
6 |
0.4 |
0.4 |
Pale |
NA |
| OA13-II:1 |
7/M |
4 |
0.3 |
0.3 |
Pale |
NA |
| OA14-I:2 |
28/F |
6 |
0.3 |
0.4 |
Pale |
NA |
| OA14-II:1 |
6/M |
3 |
0.25 |
0.3 |
Pale |
NA |
| OA15-II:1 | 14/M | 6 | 0.2 | 0.2 | Pale | NA |
Abbreviations: OD: right eye; OS: left eye; F: female; M: male; BCVA: best corrected visual acuity; VEP: visual evoked potential; NA: not available.